Cimetidine treatment for the prevention of recurrence of duodenal ulcer: an international collaborative study
Open Access
- 1 March 1980
- journal article
- research article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 56 (653), 173-176
- https://doi.org/10.1136/pgmj.56.653.173
Abstract
Summary: Comparison of cimetidine and placebo in the prevention of recurrence of ulceration was carried out in the study of 696 patients with recently healed duodenal ulcers. Treatment with cimetidine 400 mg at bedtime or twice daily for up to 12 months very significantly reduced recurrence of symptomatic ulceration. Asymtomatic ulceration occurred in treated and untreated patients but was found significantly less often in cimetidine-treated patients. There were no serious untoward effects of cimetidine treatment. Only 3 patients (0.8%) were withdrawn for possible drug-related reasons. Evidence from other studies suggests that the natural history of duodenal ulcer remains unaltered when cimetidine treatment is stopped after one year. Investigations have been planned to study the efficacy and safety of longer periods of treatment.This publication has 10 references indexed in Scilit:
- Controlled trial of maintenance cimetidine treatment in healed duodenal ulcer: short and long-term effects.Gut, 1979
- Double-blind comparison of cimetidine and placebo in the maintenance of healing of chronic duodenal ulceration.Gut, 1979
- Prophylactic effect of cimetidine in duodenal ulcer disease.BMJ, 1978
- Long term cimetidine in the management of severe duodenal ulcer dyspepsiaGastroenterology, 1978
- MAINTENANCE TREATMENT OF RECURRENT PEPTIC ULCER BY CIMETIDINEThe Lancet, 1978
- ORAL CIMETIDINE IN SEVERE DUODENAL ULCERATIONThe Lancet, 1977
- CIMETIDINE IN THE TREATMENT OF ACTIVE DUODENAL AND PREPYLORIC ULCERSThe Lancet, 1976
- A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.1965
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965